Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993.Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration (FDA) and has been prescribed to several thousands of patients in the United States.As of 2014 the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Incyte is implementing good security practices.
Read more about the latest issues in cybersecurity
The purpose of a vendor management policy is to identify which vendors put your organization at ...
For many businesses, global third-party vendors have become an important source of strategic ...
Compare Incyte's security performance with other companies